ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction
2003; Oxford University Press; Volume: 24; Issue: 16 Linguagem: Inglês
10.1016/s0195-668x(03)00322-1
ISSN1522-9645
Autores Tópico(s)Atrial Fibrillation Management and Outcomes
ResumoAims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), substantially reduced ischemic complications of acute myocardial infarction as compared with unfractionated heparin (UH). We compared ST resolution in each of the three treatment regimens in order to evaluate the speed, extent and stability of ST segment resolution and its relationship to the primary composite endpoint(s) of the trial.
Referência(s)